SightfileU.S. market data from official filings

Companies › XGN

EXAGEN INC (XGN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001274737 · EDGAR filings · Updated 2026-06-22

EXAGEN INC (XGN) has reported institutional ownership of 40.2%, with 61 institutional managers holding positions valued at $29.0M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02).

Institutional ownership
40.2%
Institutional managers
61
Reported 13F value
$29.0M
Insider activity
9 trans.
−$679.9K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EXAGEN INC has 61 institutional holders and institutional ownership of 40.2%.

Insider activity

Insiders reported 9 transactions (0 buys, 5 sells) across 3 reporting insiders, with a net reported value of −$679.9K.

Data flags from SEC filings

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2022-11-14 (recurring since 2022-11-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

LENSAR INC (LNSR) · CAPSOVISION INC (CV) · ALPHA TAU MEDICAL LTD (DRTS) · Elicio Therapeutics Inc (ELTX) · CANOPY GROWTH CORPORATION (CGC) · ACCURAY INC DEL (ARAY)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.